Vincristine News and Research

RSS
Vincristine is the active ingredient in a drug used to treat acute leukemia. It is used in combination with other drugs to treat Hodgkin disease, non-Hodgkin lymphoma, rhabdomyosarcoma, neuroblastoma, and Wilms tumor. Vincristine is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division. It is a type of vinca alkaloid and a type of antimitotic agent.
Pattern of gene expression predicts multiple drug resistance, treatment failure in pediatric leukemia

Pattern of gene expression predicts multiple drug resistance, treatment failure in pediatric leukemia

Gene expression pattern predicts multiple drug resistance

Gene expression pattern predicts multiple drug resistance

Researchers turn fatal brain cancer into treatable disease for children

Researchers turn fatal brain cancer into treatable disease for children

FDA knocks back anticancer drug Marqibo

FDA knocks back anticancer drug Marqibo

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

Thalidomide shows promise in fighting myeloma

Thalidomide shows promise in fighting myeloma

Researchers step closer to cure for common childhood cancer

Researchers step closer to cure for common childhood cancer

Guideline evaluates treatments for postherpetic neuralgia

Guideline evaluates treatments for postherpetic neuralgia

Cell Therapeutics receives Fast Track Designation for Pixantrone, treatment for aggressive non-Hodgkin's lymphoma

Cell Therapeutics receives Fast Track Designation for Pixantrone, treatment for aggressive non-Hodgkin's lymphoma

New drugs ease treatment of multiple myeloma

New drugs ease treatment of multiple myeloma